选择性激光小梁成形术与氩激光小梁成形术在既往接受360°SLT治疗青光眼患者中的等效性随机对照试验
本研究为随机单盲等效性临床试验,纳入加拿大7个中心既往接受360°SLT药物治疗未控制的开角型青光眼患者,随机接受180°SLT或ALT。12个月时两组眼压降幅分别为3.16 mmHg和2.83 mmHg,差异0.33 mmHg无统计学意义(P=0.71),但SLT在1周和1月时降眼压更显著,且失败时间分析多倾向于SLT。
要点
- 既往360°SLT后,180°SLT与ALT在12个月降眼压效果等效,降幅约3 mmHg。
- SLT在术后1周和1月降眼压优于ALT,但3个月时差异消失。
- 重复SLT的降眼压效果约为初次SLT的一半。
核心结论
- 12个月随访时SLT与ALT均降低眼压约3 mmHg,等效性成立,但失败时间分析多倾向于SLT。
研究设计与样本
- 随机、单盲、等效性、平行组主动对照临床试验,纳入加拿大7个中心的开角型青光眼(含色素播散综合征和假性剥脱综合征)患者。
- 共招募132例,2例早期退出,130例按方案完成研究并计算主要结局。
- 每例患者随机接受180°SLT或ALT一次治疗。
主要发现
- SLT组与ALT组12个月眼压较基线降幅分别为3.16 mmHg和2.83 mmHg,组间差异0.33 mmHg,无统计学意义(P=0.71)。
- SLT在术后1周和1月时降眼压显著优于ALT,但该差异在3个月时消失。
- 失败时间分析强烈倾向于ALT比SLT更快失败。
- 重复SLT可重复,但首次重复SLT降眼压效果仅为初次SLT的约一半。
临床怎么用
- 对既往接受360°SLT后药物未控制的开角型青光眼,180°SLT与ALT在12个月降眼压等效,均可作为选择。
- SLT早期降眼压更明显且失败更慢,可优先考虑SLT。
- 重复SLT的降眼压效应约为初次的一半,需预期效果减弱。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: The effectiveness of selective laser trabeculoplasty (SLT) was compared with argon laser trabeculoplasty (ALT) in a randomized clinical trial for patients with medically uncontrolled open-angle glaucoma who have previously received 360° SLT. DESIGN: An active equivalence parallel armed randomized control trial. PARTICIPANTS: Patients with open-angle glaucoma including pigmentary dispersion syndrome and pseudoexfoliation syndrome were enrolled into the study from 7 different sites across Canada. METHODS: One setting of 180° of either SLT or ALT was assigned randomly and applied to each participant. MAIN OUTCOME MEASURES: The change in intraocular pressure (IOP) from baseline to 12 months was compared between the 2 groups. RESULTS: A total of 132 patients were recruited, 2 of which dropped out early in the study, leaving 130 patients who completed the study as per protocol. For those, the study's primary outcome was calculated. The IOP change at 1 year in comparison to baseline for SLT vs. ALT was found to be different by 0.33 mmHg between the 2 groups (3.16 for SLT and 2.83 for ALT) and was not statistically significant (P = 0.71) Further analysis, though, showed that SLT had a significantly lower IOP reduction at early time points: 1 week and 1 month, but this effect was lost by 3 months. Corresponding to this finding was the strong trend for ALT to fail more quickly than SLT. Although repeatable, the first repeat SLT reduced IOP to only about half compared with initial SLT treatment. CONCLUSIONS: The comparison at 12 months following the laser therapy showed that both modalities lowered the IOP with approximately 3 mmHg, yet essentially all of the time-to-failure analyses favored SLT over ALT. The repeat SLT effect was found to be half of the initial treatment.
引用
- Hutnik C, Crichton A, Ford B, et al. Selective Laser Trabeculoplasty versus Argon Laser Trabeculoplasty in Glaucoma Patients Treated Previously with 360° Selective Laser Trabeculoplasty: A Randomized, Single-Blind, Equivalence Clinical Trial. Ophthalmology. 2018. PMID: 30278197. doi:10.1016/j.ophtha.2018.09.037
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。